Jonathan Sabbagh is building a space and solution for independent therapists who want to provide Ketamine-assisted psychotherapy (KAP) by offering a prescription service, a medically supervised location, and a community.
On the show, we talk about Jonathan’s startup Journey and the tools he is creating to democratize access for independent psychedelic practitioners. We discuss set and setting and the Journey space. We talk about vetting and training psychedelic therapist and how Journey endeavors can create community. We also go over concerns around the medicalization of psychedelics.
Jonathan is the Co-founder and CEO of Journey Clinical Inc and is currently studying to be a psychedelic therapist himself at The New School. After 20 years in finance and entrepreneurship, he is bringing his skills and passion into the psychedelic community with the support of his own deep medicine work.
As the adoption of psychedelic therapy grows worldwide, support services for independent practitioners, like Journey, will be invaluable.
Links
Timestamps
